-
Signature
-
/s/ Ewelina Kemp, Attorney-in-Fact for Alan Trefler
-
Issuer symbol
-
PEGA
-
Transactions as of
-
10 Jul 2025
-
Net transactions value
-
-$2,328,607
-
Form type
-
4
-
Filing time
-
14 Jul 2025, 17:10:52 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| TREFLER ALAN |
C.E.O. & Chairman, Director, 10%+ Owner |
C/O PEGASYSTEMS INC., 225 WYMAN STREET, STE 300, WALTHAM |
/s/ Ewelina Kemp, Attorney-in-Fact for Alan Trefler |
14 Jul 2025 |
0001032235 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PEGA |
Common stock |
Sale |
$1,690,622 |
-32,764 |
-0.1% |
$51.60 |
33,018,928 |
10 Jul 2025 |
Direct |
F1, F2 |
| transaction |
PEGA |
Common stock |
Sale |
$637,985 |
-12,236 |
-0.04% |
$52.14 |
33,006,692 |
10 Jul 2025 |
Direct |
F1, F3 |
| holding |
PEGA |
Common stock |
|
|
|
|
|
3,211,006 |
10 Jul 2025 |
Alan N. Trefler Irrevocable Non-GST Trust of 2022 |
|
| holding |
PEGA |
Common stock |
|
|
|
|
|
10,134,542 |
10 Jul 2025 |
Alan N. Trefler Grantor Retained Annuity Trust I of 2023 |
|
| holding |
PEGA |
Common stock |
|
|
|
|
|
4,381,472 |
10 Jul 2025 |
Alan N. Trefler Grantor Retained Annuity Trust II of 2023 |
|
| holding |
PEGA |
Common stock |
|
|
|
|
|
15,000,000 |
10 Jul 2025 |
Alan N. Trefler Grantor Retained Annuity Trust I of 2024 |
|
| holding |
PEGA |
Common stock |
|
|
|
|
|
12,000,000 |
10 Jul 2025 |
Alan N. Trefler Grantor Retained Annuity Trust II of 2024 |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: